Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy (including a review of TA140 and TA262): clinical effectiveness systematic review and economic model
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Hasan Başarır Shijie Ren Rachel Archer |
| Publication date | May 1, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |